
Pharma industry is R/evolving to a new entity either in drugdiscovery or production
area. CinnaGen Biopharma has been generated during this R/evolution,
in 1999.
CinnaGen Biopharma started with production of some peptide hormones and
sent a group of synthetic peptides to market.
Using the experience of the hormone production CinnaGen Biopharma started
production line for some biopharmaceuticals including human interferon beta-1a and
erythropoietin.
Now CinnaGen Biopharma tends to play a major role in biotech production,
particularly biogeneric/biosimilar production in the region.
Our aim at CinnaGen Biopharma is providing cure and treatment for most
important health challenges of the world.
With about 50 members of expert team and technicians Our expert team at CinnaGen
Biopharma is working CinnaGen values to help society to improve people’s
live.
|